To determine whether p53 peptides function as tumor antigens, we employed an ELISPOT assay using a mixture of synthetic p53 peptides: p5363-70 (APRMPEAA), p5365-73 (RMPEAAPPV), and p5372-79 (PVAPAPAA). The gene discussed is TP53; the disease is neoplasm.